We have previously shown in preclinical models that small molecules inhibiting ROR1, KAN0439834 and KAN0441571C, induced tumor cell death in CLL and DLBCL cells which express activated ROR1 [5, 10]. The gene discussed is ROR1; the disease is neoplasm.